110 related articles for article (PubMed ID: 38826177)
1. Response to Letter Regarding Article, The Role of COVID-19 Vaccination for Patients With Atherosclerotic Cardiovascular Disease in the Upcoming Endemic Era.
Kim KH
J Lipid Atheroscler; 2024 May; 13(2):213-214. PubMed ID: 38826177
[No Abstract] [Full Text] [Related]
2. Letter by Hinpetch Daungsupawong Regarding Article, The Role of COVID-19 Vaccination for Patients With Atherosclerotic Cardiovascular Disease in the Upcoming Endemic Era.
Daungsupawong H; Wiwanitkit V
J Lipid Atheroscler; 2024 May; 13(2):212. PubMed ID: 38826185
[No Abstract] [Full Text] [Related]
3. The Role of COVID-19 Vaccination for Patients With Atherosclerotic Cardiovascular Disease in the Upcoming Endemic Era.
Kim KH
J Lipid Atheroscler; 2024 Jan; 13(1):21-28. PubMed ID: 38299160
[TBL] [Abstract][Full Text] [Related]
4. Letter to the editor: Increase of influenza vaccination coverage rates during the COVID-19 pandemic and implications for the upcoming influenza season in northern hemisphere countries and Australia.
Del Riccio M; Lina B; Caini S; Staadegaard L; Wiegersma S; Kynčl J; Combadière B; MacIntyre CR; Paget J
Euro Surveill; 2021 Dec; 26(50):. PubMed ID: 34915972
[No Abstract] [Full Text] [Related]
5. Coronavirus Disease 2019 (COVID-19) set to increase burden of atherosclerotic cardiovascular disease in Kenya.
Ogeng'o J; Karau PB; Misiani M; Cheruiyot I; Olabu B; Kariuki BN
Pan Afr Med J; 2020; 35(Suppl 2):120. PubMed ID: 33282075
[TBL] [Abstract][Full Text] [Related]
6. The impact of vaccination and outpatient treatment on the economic burden of Covid-19 in the United States omicron era: a systematic literature review.
Pierre V; Draica F; Di Fusco M; Yang J; Nunez-Gonzalez S; Kamar J; Lopez S; Moran MM; Nguyen J; Alvarez P; Cha-Silva A; Gavaghan M; Yehoshua A; Stapleton N; Burnett H
J Med Econ; 2023; 26(1):1519-1531. PubMed ID: 37964554
[TBL] [Abstract][Full Text] [Related]
7. Effect of Electronic Nudges on Influenza Vaccination Rate in Older Adults With Cardiovascular Disease: Prespecified Analysis of the NUDGE-FLU Trial.
Modin D; Johansen ND; Vaduganathan M; Bhatt AS; Lee SG; Claggett BL; Dueger EL; Samson SI; Loiacono MM; Køber L; Solomon SD; Sivapalan P; Jensen JUS; Jean-Marie Martel C; Valentiner-Branth P; Krause TG; Biering-Sørensen T
Circulation; 2023 May; 147(18):1345-1354. PubMed ID: 36871213
[TBL] [Abstract][Full Text] [Related]
8. Racial and geographic disparities in influenza vaccination in the U.S. among individuals with atherosclerotic cardiovascular disease: Renewed importance in the setting of COVID-19.
Al Rifai M; Khalid U; Misra A; Liu J; Nasir K; Cainzos-Achirica M; Mahtta D; Ballantyne CM; Petersen LA; Virani SS
Am J Prev Cardiol; 2021 Mar; 5():100150. PubMed ID: 33521756
[TBL] [Abstract][Full Text] [Related]
9. Modeling Incorporating the Severity-Reducing Long-term Immunity: Higher Viral Transmission Paradoxically Reduces Severe COVID-19 During Endemic Transition.
Hong H; Noh JY; Lee H; Choi S; Choi B; Kim JK; Shin EC
Immune Netw; 2022 Jun; 22(3):e23. PubMed ID: 35799710
[TBL] [Abstract][Full Text] [Related]
10. Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data.
Dreyfus J; Munnangi S; Bengtsson C; Correia B; Figueiredo R; Stark JH; Zawora M; Riddle MS; Maguire JD; Jiang Q; Ianos C; Naredo Turrado J; Svanström H; Bailey S; DeKoven M
Vaccine; 2024 Feb; 42(5):1094-1107. PubMed ID: 38262807
[TBL] [Abstract][Full Text] [Related]
11. Letter to the editor to: Verger P and Dubé E. Restoring confidence in vaccines in the COVID-19 era, expert review of vaccines, 2020; 19(11):991-3.
Ridda I; Chamberlain R; Haber R; Rashid H
Expert Rev Vaccines; 2021 Apr; 20(4):479-481. PubMed ID: 33740876
[No Abstract] [Full Text] [Related]
12. Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination: A New Diagnostic Dilemma.
Ashoor A; Shephard J; Lissidini G; Nicosia L
Korean J Radiol; 2022 Jul; 23(7):775-776. PubMed ID: 35695318
[No Abstract] [Full Text] [Related]
13. Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement.
Bhugra P; Grandhi GR; Mszar R; Satish P; Singh R; Blaha M; Blankstein R; Virani SS; Cainzos-Achirica M; Nasir K
J Am Heart Assoc; 2021 Aug; 10(15):e019671. PubMed ID: 34315229
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Pandemic-to-Endemic Transition in Indonesia: What Does the Future Hold?
Sinto R
Acta Med Indones; 2022 Apr; 54(2):159-160. PubMed ID: 35818655
[TBL] [Abstract][Full Text] [Related]
15. Safely navigating kidney transplantation during the COVID-19 pandemic: the Singapore General Hospital's experience.
Tien CS; Liew IT; Ho QY; Thangaraju S; Rahman MBA; Lee C; Leah NCXH; He X; Siew LT; Kee TYS
Korean J Transplant; 2023 Jun; 37(2):95-102. PubMed ID: 37435150
[TBL] [Abstract][Full Text] [Related]
16. Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort study.
Cezard GI; Denholm RE; Knight R; Wei Y; Teece L; Toms R; Forbes HJ; Walker AJ; Fisher L; Massey J; Hopcroft LEM; Horne EMF; Taylor K; Palmer T; Arab MA; Cuitun Coronado JI; Ip SHY; Davy S; Dillingham I; Bacon S; Mehrkar A; Morton CE; Greaves F; Hyams C; Davey Smith G; Macleod J; Chaturvedi N; Goldacre B; Whiteley WN; Wood AM; Sterne JAC; Walker V;
Nat Commun; 2024 Mar; 15(1):2173. PubMed ID: 38467603
[TBL] [Abstract][Full Text] [Related]
17. Acceptance of Seasonal Influenza Vaccine Following COVID-19 Vaccination: A Survey among Israel Defense Forces Soldiers.
Nitzan I; Akavian I; Adar O; Rittblat M; Tomer G; Shmueli O; Friedensohn L; Talmy T
Behav Med; 2024; 50(2):98-105. PubMed ID: 36073723
[TBL] [Abstract][Full Text] [Related]
18. Response by O'Donoghue et al to Letter Regarding Article, "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease".
O'Donoghue ML; Giugliano RP; Sabatine MS
Circulation; 2023 Apr; 147(16):1258-1259. PubMed ID: 37068132
[No Abstract] [Full Text] [Related]
19. Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19.
Inshasi J; Alroughani R; Al-Asmi A; Alkhaboury J; Alsalti A; Boshra A; Canibano B; Deleu D; Ahmed SF; Shatila A; Thakre M
Neurol Ther; 2021 Jun; ():1-17. PubMed ID: 34155473
[TBL] [Abstract][Full Text] [Related]
20. Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19.
Inshasi J; Alroughani R; Al-Asmi A; Alkhaboury J; Alsalti A; Boshra A; Canibano B; Deleu D; Ahmed SF; Shatila A; Thakre M
Neurol Ther; 2021 Dec; 10(2):539-555. PubMed ID: 34138444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
